Intravesical mitomycin C for superficial transitional cell carcinoma (Q36573853)

15 August 2017

1 reference

title

Intravesical mitomycin C for superficial transitional cell carcinoma (English)

1 reference

15 August 2017

1

Christian Bolenz

1 reference

15 August 2017

Yanwei Cao

2

1 reference

15 August 2017

Mario Fernández Arancibia

3

1 reference

15 August 2017

Lutz Trojan

4

1 reference

15 August 2017

Peter Alken

5

1 reference

15 August 2017

Maurice Stephan Michel

6

1 reference

15 August 2017

1 August 2006

1 reference

Expert Review of Anticancer Therapy

15 August 2017

1 reference

15 August 2017

6

1 reference

15 August 2017

1273-1282

1 reference

15 August 2017

8

1 reference

15 August 2017

Cancer statistics, 1997.

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1273

Current use and questions concerning intravesical bladder cancer group for superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1273

Guidelines on bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1273

Advances in intravesical therapy of urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1273

Eosinophilic cystitis presenting as a recurrent symptomatic bladder mass following intravesical mitomycin C therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1273

Intravesical bacille Calmette-Guérin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1273

Prophylactic intravesical instillation of mitomycin C and cytosine arabinoside for prevention of recurrent bladder tumors following surgery for upper urinary tract tumors: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1273

A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1273

Is intravesical chemotherapy for superficial bladder cancer still justified?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1273

TUR and adjuvant intravesical chemotherapy in T1G3 bladder tumors: recurrence, progression and survival in 137 selected patients followed up to 20 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1273

Intravesical therapy of superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1273

Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1273

Intravesical bacillus Calmette-Guérin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1273

Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1273

Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1273

Selective cytotoxicity of gemcitabine in bladder cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1273

Pharmacokinetics of intravesical gemcitabine: a preclinical study in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1273

Intravesical gemcitabine therapy for superficial transitional cell carcinoma: results of a Phase II prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1273

Intravesical gemcitabine for superficial bladder cancer: rationale for a new treatment option.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1273

Future strategies in the diagnosis, staging and treatment of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1273

Multicentric Study Comparing Intravesical Chemotherapy Alone and With Local Microwave Hyperthermia for Prophylaxis of Recurrence of Superficial Transitional Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1273

Mitomycin C: a clinical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1273

Superficial bladder cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1273

Bladder perforation: a potential risk of early endovesical chemotherapy with mitomycin C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1273

Distal ureteral stenosis after early adjuvant intravesical mitomycin C application for superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1273

Perivesical inflammation after early mitomycin C instillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1273

One immediate postoperative instillation of chemotherapy in low risk Ta, T1 bladder cancer patients. Is it always safe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1273

The actual incidence of bladder perforation following transurethral bladder surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1273

Preliminary European Results of Local Microwave Hyperthermia and Chemotherapy Treatment in Intermediate or High Risk Superficial Transitional Cell Carcinoma of the Bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.8.1273

10.1586/14737140.6.8.1273

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference